An evaluation of methacycline hydrochloride (6 methylene oxytetracycline).
D001249:Asthma / Q000188:drug therapy; D001796:Blood Protein Disorders / Q000188:drug therapy; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008286:Malabsorption Syndromes / Q000188:drug therapy; D008297:Male; D008690:Methacycline / Q000627:therapeutic use; D010033:Otitis Media / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013752:Tetracycline / Q000627:therapeutic use*; D014068:Tonsillectomy; D005719:gamma-Globulins
D005719:gamma-Globulins; D013752:Tetracycline; D008690:Methacycline